A Phase 1, Cross-over, Single-dose, Open-label Study to Estimate the Relative Bioavailability of Three Different Formulations of Pf-04620110 Under Fed/Fasted Conditions in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2010
At a glance
- Drugs PF 4620110 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 19 Aug 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 19 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Aug 2010 Planned end date changed from 1 Sep 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.